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Purpose: Ethanol embolotherapy is one of the established methods in the treatment of extremity arteriovenous
malformations (AVMs). The purpose of this study was to report the application of this method to hand AVMs and to
assess retrospectively the therapeutic outcomes and complications.
Patients andMethods: FromDecember 1998 toMarch 2009, we treated 31 patients with hand AVMs (16 women, 15men,
age range, 5-51 years; mean age, 27 years). With the patients under general anesthesia, they underwent staged ethanol
embolotherapy (range, 1-11 sessions; mean, 2.8 sessions) by direct puncture and or intra-arterial approach. Therapeutic
outcomes were evaluated by clinical responses of symptoms and signs, as well as the degree of devascularization on
angiography. We also divided the patients into three groups according to the extent of involvement: a group involving
fingers (n  14), a group involving fingers and parts of the palm (n  9), and a group involving parts of the palm (n 
8) and compared the therapeutic outcomes and complications among groups.
Results:One patient (3%) was cured, 22 patients (73%) showed improvement, and 7 patients (23%) showed no change or
aggravation after the treatment. One patient was lost to follow-up. Nineteen patients (61%) had one or more
complications, including skin necrosis in 14 patients (45%), bullae in 7 patients (23%), joint stiffness or contracture in 6
patients (19%), and transient nerve palsy in 4 patients (13%). All of the complications were resolved completely after 1 to
8 months’ (average, 3.4 months) follow-up, except in 2 patients who underwent amputation. According to the location
of AVMs, rates of therapeutic benefit and complications were 93% and 64% in the group involving fingers, 38% and 78%
in the group involving fingers and the palm, and 88% and 38% in the group involving the palm, respectively.
Conclusion:Ethanol embolotherapy of handAVMs improves symptoms in a certain percentage of patients with a relatively
high risk of complications. According to the extent of AVMs, there was a trend toward a higher complication rate in
treatment of AVMs involving fingers and a lower rate of therapeutic benefit in AVMs involving both the fingers and the
palm. (J Vasc Surg 2011;53:725-31.)
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uArteriovenous malformation (AVM) can occur on any
part of the body and upper extremities, including the hand,
which is the secondmost common part of the body, next to
the head and neck.1 An AVM of the hand is usually small in
size, but can cause more disability, pain, and discomfort
than the lesion of any other part of the extremities due to its
delicate motion and keen sense.
Treatment of hand AVMs has more risk of complica-
tion and failure due to its complex and rich neurovascular
network, and because the region is quite small, and, there-
fore, normal vessels are located in close proximity and it is
sometimes difficult to discriminate between normal and
AVM vessels. Surgical resection or ligation of AVM is
extremely difficult and can result in permanent disability or
recurrence due to recruitment of reconstituted arterial flow
into the nidus.2-5
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doi:10.1016/j.jvs.2010.09.028Interventional management using a variety of embolic
aterial has been an important mode of treatment for the
anagement of extremity AVM in many literatures, and
thanol is widely used.6-8 There have been only a few
tudies reporting the results of embolization with n-butyl
yanoacrylate (NBCA) or surgery in treatment of hand
VMs.4,5,9-11 The purpose of our study was to evaluate the
herapeutic outcome and complications of ethanol embo-
otherapy of the hand AVM retrospectively.
ETHODS
Patients. Approval from the institutional review board
as obtained for a retrospective review of the patients’
edical records and radiologic images; however, informed
onsent was not required. Written consent for the proce-
ure was obtained from all patients.
From December 1998 to March 2009, 35 consecutive
atients with hand AVMs were referred to our vascular
alformation clinic (authors H.S.P., Y.S.D., K.B.P., D.K.,
.W.K., and B.S.S.). Hand AVMs with severe ulceration
nd necrosis of overlying skin and uncontrolled infection
ere contraindications to ethanol embolotherapy, fearing
ggravation of tissue damage, and for those reasons 4
atients underwent amputation. Thirty-one patients (16
omen; 15men; mean age, 27 years; age range, 5-51 years)
nderwent a staged ethanol embolotherapy using the intra-
rterial or direct puncture method.
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March 2011726 Park et alPresenting symptoms and signs included pain, swelling,
or mass with or without pulsation, bluish discoloration,
weakness of the hand, and necrosis. Patients usually had
more than one symptom and sign. There were 5 patients
who had residual or recurrent symptoms or signs after
previous unsuccessful treatment, which were embolization
of feeding arteries with NBCA and ethanol in 2 patients at
the other hospital, amputation of necrotic fingers in 2
patients, and partial surgical removal of AVM in 1 patient.
Patients were divided into three groups according to
the extent of involvement: fingers in 14 patients (group I),
fingers and parts of the palm in 9 patients (group II), and
part of the palm in 8 patients (group III; Table). Three
patients in group I and 7 patients in group II had involve-
ment of multiple fingers.
Diagnosis and follow-up of AVM was based on clinical
findings and imaging studies, including ultrasound scan,
computed tomography (CT), magnetic resonance imaging
(MRI), and whole body blood pool scan.12,13
A CT scan was performed with an 8-to-64 channel
Table. Clinical data and results of ethanol embolization in
Patient No./
gender/age
(year) Location
Sessions of
embolization Approach C
I 1/M/31 3f 1 TA & D Necr
2/F/22 3f 1 D Non
3/F/51 1f 1 TA Pare
4/F/23 3f 4 TA & D Necr
5/F/22 2f 2 TA & D Non
6/F/30 5f 1 TA & D Non
7/F/27 1f 3 TA & D Necr
8/M/20 1f 1 TA Stiffn
9/F/42 3f/4f 3 TA & D Pare
10/F/14 4f/5f 1 TA Non
11/M/23 2f/3f/4f 2 D Stiffn
12/M/17 4f 4 TA & D Non
13/M/9 4f 7 TA & D Necr
14/M/22 1f 1 D Wea
II 15/M/5 2f/mc/c 2 TA Blee
16/F/25 1f/thenar 2 TA & D Necr
17/F/32 2f/3f/mc/c 3 TA & D Stiffn
18/M/13 2f/3f/4f/5f/
mc/c
11 TA & D Non
19/F/42 3f/mc 4 TA & D Necr
20/M/36 4f/5f/mc/c 3 TA & D Necr
21/M/51 3f/4f/5f/mc 4 D Necr
th
22/M/17 2f/3f/mc/c 2 TA & D Non
23/F/36 2f/3f/mc/c 3 D Necr
III 24/F/33 Mc 2 TA & D Non
25/F/17 Thenar 4 TA & D Necr
26/M/21 Mc 4 TA & D Non
27/F/36 Mc 3 TA Non
28/F/45 Mc/c 1 TA & D Necr
29/M/15 Mc 3 TA & D Non
30/M/38 Mc 2 TA & D Non
31/M/34 Mc 1 D Necr
c, Carpal;D, direct puncture; f, finger (numbers stand for the ordinal numbe
III, involvement of palm; Mc, metacarpal; TA, transarterial.MDCT (Lightspeed; GE Medical Systems, Milwaukee, Bisc; Brilliance 40; Philips, Best, The Netherlands; Aquil-
on 64 Toshiba, Tokyo, Japan). Arterial phase was obtained
fter injection of 120 mL (4 mL/sec injection rate) of
onionic contrast material and then 40 mL (2 mL/sec
njection rate) of normal saline solution with an automatic
njector. Bolus triggering methods were used routinely to
nsure appropriate scan timing. CT images included thin
ection axial images, as well as maximum intensity projec-
ions, multiplanar reconstruction, and volume-rendered
mages. MRI scans was performed using a 1.5-T unit
Signa; GE Medical Systems). The MRI protocol included
ransverse, sagittal, and coronal imaging with T1-weighted
nd gradient-echo sequences (field of view, 8-12 mm;
pacing, 10-14 mm; matrix, 256  192). Selective and
uperselective angiography was required to accurately de-
ne the feeding arteries, draining veins, and nidus of the
VMs.
Embolization procedure and follow-up. All proce-
ures were performed with the patients under general anes-
hesia according to previously described techniques.7,8,14
atients
lications
Follow-up
(month)
Degree of
devascularization
(%) Outcome
weakness 60 100 Cure
18 76-99 Improved
a 24 76-99 Improved
contracture 12 76-99 Improved
12 76-99 Improved
20 76-99 Improved
27 76-99 Improved
necrosis 7 76-99 Improved
a 6 76-99 Improved
4 76-99 Improved
necrosis 25 79-99 Improved
60 50-75 Improved
48 50-75 Improved
17 76-99 No change
59 76-99 Improved
stiffness 4 76-99 Improved
24 76-99 Improved
24 50 No change
stiffness 26 50 Failure
(amputation)
6 50 Failure
(autoamputation)
venous
osis
6 50 Failure
6 nc Failure
Loss 50-75 F/U loss
53 100 Improved
17 76-99 Improved
25 76-99 Improved
31 76-99 Improved
3 76-99 Improved
20 76-99 Improved
20 50-75 Improved
5 50 Failure
ngers); I, involvement of finger; II, involvement of finger and part of palm;31 p
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Volume 53, Number 3 Park et al 727was obtained for evaluation of the extent and hemody-
namic characteristics of the AVMs and for selection of
access route, transarterial, direct puncture, or both. We
punctured the right common femoral artery with the
Seldinger technique and inserted a 6F arterial sheath. The
arterial sheath was flushed continuously through the side arm
with normal saline solution during the procedure. We cathe-
terized the brachial arterywith a 4 to 5F angiographic catheter
and obtained an angiogram. In the transarterial approach, 2 to
3F microcatheters were superselectively advanced as close
as possible to the nidus, and an angiogram was obtained
again. In using the direct puncture method, the nidus was
punctured with a 21-gauge needle, checking backflow of
blood by gentle aspiration. To determine the volume and
injection rates of ethanol, test injections of contrast media
were made under fluoroscopic monitoring. The amount of
ethanol used was based on the amount of contrast media
required to fill the AVM nidus without opacifying normal
vessels. Absolute ethanol was used in most cases; 50% to
80% ethanol mixed with a nonionic contrast media (Xenetix
300; Guerbet, Cedex, France) was used in some AVMs. In
some cases with massive arteriovenous shunting, we used a
blood pressure cuff or automatic tourniquet system (ATS
1500; Zimmer, Dover, Ohio) to achieve vascular stasis.
After inflation of the pressure cuff or automatic tourniquet
system to 150 to 250 mm Hg, we performed an angiogra-
phy and checked the volume of contrast medium to fill the
AVM nidus and any contrast medium reflux to the normal
artery. If there was contrast medium reflux to the normal
artery, we reduced the pressure of the cuff and performed
the same procedure until there was no reflux to the normal
artery before injecting ethanol. The pressure cuff or tour-
niquet system was left inflated for 5 to 7 minutes.
Five to 10 minutes after ethanol injection, an arterio-
gram was performed for evaluation of the response to
embolization. Repetition of these techniques was required
for complete embolization of targeted region of the AVMs.
Swan-Ganz catheterization and arterial line monitoring
were performed in all patients to monitor pulmonary artery
pressure and arterial blood pressure during the procedure.
All patients were closely followed for complications and
discharged within 24 hours.
Follow-up evaluation, including physical examination,
color Doppler imaging, CT, whole body blood pool scan,
or MRI, was performed at 1 to 6 months. Additional
embolization was recommended if the symptoms and signs
remained or recurred.
Two interventional radiologists (H.S.P. and Y.S.D.)
analyzed by consensus the therapeutic response to ethanol
embolization by comparing the degree of AVM devascu-
larization (100%, 76% to 99%, 50% to 75%,50%) between
the initial and final angiography. Clinical response was
evaluated depending on the subjective change of symptoms
and signs (complete resolution, partial resolution, no
change, and aggravation). Therapeutic outcomes were as-
sessed according to the degree of angiographic devascular-
ization and clinical response. Cure was defined as complete
resolution of symptoms and signs, with 100% devascular- ezation of AVMs at angiography. Improvement was defined
s complete or partial resolution of symptoms and signs,
ith 50% to 99% AVM devascularization at angiography.
o change was defined as partial resolution or no change of
ymptoms and signs with 50% devascularization at an-
iography. Failure was defined as aggravation of symptoms
nd signs, regardless of the degree of AVM devasculariza-
ion at angiography or amputation of the involved finger.
ure and improvement were considered as effective thera-
eutic benefits of ethanol embolization.
Major complications included death, permanent ad-
erse sequelae, a need for amputation, and prolonged hos-
italization (48 hours). Minor complications included
ny nonpermanent adverse sequelae, such as transient nerve
njuries or a skin injury that healed spontaneously.
Clinical follow-up after the last treatment session
anged from 4 to 60 months (mean, 22 months; median,
7 months) in 30 patients.
Post hoc test using the Bonferroni method was per-
ormed for comparison of therapeutic outcome and Fisher
xact test for comparison of complication rates among the
hree groups.
ESULTS
Thirty-one patients underwent 86 sessions of embolo-
herapy (mean, 2.8; range, 1-11), which included 37 ses-
ions using direct puncture, 34 using the transarterial
ethod, and 15 using both (Table). Average volume of
thanol was 19.7 cc (range, 4-54 cc), and there was 1 case
ith a large arteriovenous shunt using additional coils
Nester, Cook, Bloomington, Ind) for embolization of a
ilated draining vein through a direct puncture route to
ecrease blood flow and thus the amount of ethanol. Coils
ere removed surgically 2 years later. Average duration of
he procedure was 2.4 hours (range, 1.3-3.5 hours). There
as no case with pulmonary arterial pressure increased to
ver 25 mm Hg after ethanol embolotherapy and no need
or management using nitroglycerin to lower pulmonary
rterial pressure.
AVMs were cured in 1 patient (3%), improved in 22
atients (73%), unchanged in 2 patients (7%), and aggra-
ated in 5 patients (17%). One patient was lost to follow-
p. Complications occurred in 19 patients (61%) without
rocedure-related mortality. All complications were minor
nd transient, except for 2 patients who underwent ampu-
ation of necrotic fingers. These complications completely
isappeared after 1 to 8 months (average, 3.4 months)
ollow-up. Almost all patients had transient swelling and
ain that lasted no longer than 2 weeks and they were not
ounted as complications.
Finger arteriovenous malformation (group I; pa-
ients 1-14; n 14). In cases involving single or multiple
ngers, the degree of devascularization was 100% in 1
atient (7%), 76% to 99% in 11 patients (79%), and 50% to
5% in 2 patients (14%). In consideration of the symptoms
nd signs, AVMs were cured in 1 patient (7%), improved in
2 patients (86%), and unchanged in 1 patient (7%) after
thanol embolization.
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March 2011728 Park et alNine patients (64%) had one or more minor complica-
tions; necrosis in 6 patients (43%), transient motor or
sensory nerve injury in 4 patients (29%), and joint stiffness
or contracture in 3 patients (21%). These complications
completely disappeared after 2 to 6 months (average, 3.8
months) follow-up.
In 1 patient (patient 1; Fig 1), the AVMwas completely
devascularized after one session of ethanol embolotherapy,
and symptoms were completely alleviated. Necrosis of the
fingertips and motor weakness occurred, but were gradu-
ally and completely resolved during the follow-up period.
Arteriovenous malformations of both finger and
palm (group II; patients 15-23; n  9). Nine patients
Fig 1. Patient 1. A 31-year-old man with swelling of the 3rd
finger. A, Pretreatment angiography shows dense opacification of
arteriovenous malformation (AVM) niduses and draining veins. B,
The intra-arterial approach failed, because the feeding arteries were
too small and too many to catheterize selectively. We changed to
direct puncture and ethanol infusion. C, Complete obliteration of
AVM was achieved after injection of 7 mL of ethanol. The patient
has remained asymptomatic for the past 5 years.had AVMs involving single or multiple fingers and part of dhe palm. The degree of devascularization was 76% to 99%
n 3 patients (33%), 50% to 75% in 1 patient (11%), and less
han 50% in 5 patients (56%). AVMs were improved in 3
atients (3 of 8; 38%), unchanged in 1 patient (1 of 8; 13%),
nd were aggravated in 4 patients (4 of 8; 50%; Fig 2). One
atient was lost to follow-up 6 months after the last session
f embolotherapy.
Seven patients had one or more complications (78%),
ecrosis in 5 patients (56%), joint stiffness in 3 patients
33%), venous thrombosis in 1 patient (11%), and bleeding
rom the necrotic wound in 1 patient (11%).
In 4 patients with treatment failure, catheterization and
uncture were impossible due to tortuosity of feeding
rteries and fine microfistulae. In 1 patient (patient 19),
urgical amputation of the finger was required due to
ecrosis, and in another patient (patient 20), autoamputa-
ion developed at the involved fingertip after the last session
f embolotherapy.
Palm arteriovenous malformations (group III; pa-
ients 24-31; n  8). In patients with palm AVMs, the
ig 2. Patient 21. A 51-year-old man with pulsating mass and
oint contracture in the 3rd, 4th, and 5th fingers and metacarpal
rea. A, Angiography demonstrates dilated arterial and venous
ilatation with dense opacification. B, After four sessions of etha-
ol embolization, arteriovenous malformation (AVM) of the 3rd
nger shows devascularization with recovery of joint contracture.
owever, other parts rarely responded and thrombosis developed
n radial and ulnar veins, resulting in necrosis and subsequent
nfection.egree of devascularization was 100% in 1 patient (13%;
h
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Volume 53, Number 3 Park et al 729Fig 3), 76% to 99% in 5 patients (63%), 50% to 75% in 1
patient (13%), and less than 50% in 1 patient (13%). AVMs
were improved in 7 patients (88%). One patient (patient 31),
who had undergone amputation of involved fingers and em-
bolizationwith anNBCA in another hospital, had aggravation
of necrosis and complained of aggravation of symptoms after
one session of ethanol embolotherapy. The necrotic wound
healed 6months after embolotherapy, but the patient refused
further treatment, resulting in treatment failure.
Complications occurred in 3 patients (38%); all were
necrosis, which healed completely in 2 patients.
According to the location of the AVMs, the rate of ther-
Fig 3. Patient 24. A 33-year-old woman with a pulsating
increased uptake of arteriovenous malformation (AVM; arr
and tortuously dilated vein (arrowheads).C, After two sessi
the AVM and the dilated vein disappeared completely.D,
embolotherapy, was normalized. However, she complained
improved.apeutic benefit (cure and improvement) was significantly tigher in group I than in group II (93% vs 38%, respectively;
 .0190).However, therewas no difference between group
and group III (93% vs 88%;P 1.0000) and between group
I and group III (38% vs 88%; P  .1830). The rate of
omplications was relatively higher in AVMs involving fingers
64% in group I; 78% in group II) than in those without
nvolvement of fingers (38% in group III); however, the
ifference was not significant (P .2854).
ISCUSSION
Ethanol embolization has been proven effective and
elatively safe in the management of AVM of extremi-
on the left palm. A, Whole body blood pool scan shows
d). B, Angiography demonstrates arteriovenous shunting
f transarterial and direct puncture ethanol embolotherapy,
e body blood pool scan, obtained 4 years after the second
ild discomfort when grabbing objects, and was classified asmass
owhea
ons o
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of mies.2,7,8,14 In our series with hand AVMs, complete oblit-
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March 2011730 Park et aleration of AVM vessels and cure were obtained in just 1
patient (3%) and this cure rate is low compared with the
32% to 40% cure rate of AVMs of other locations.7,8
However, symptomatic improvement occurred in 64% of
patients, and this improvement rate is comparable to the
68% improvement rate of AVMs of other extremities.7,15
The hand is a small region and there may be an intimate
relationship between normal and abnormal vessels.16 It is
not easy to puncture or catheterize the nidus and to dis-
criminate between AVM vessels and normal vessels on
angiography. The possibilities of reflux into or inevitable
embolization of normal vessels are greater than those in
embolization for AVM of any other part of the body.
Understanding the hemodynamic characteristics of AVM
thorough angiography is essential for determination of the
therapeutic approach, as we reported previously.8,14 Metic-
ulous infusion technique and reduction of the amount of
ethanol to the minimum was required to reduce the com-
plications. Despite our efforts, the complication rate was
61%, higher than that of AVMs of other locations, but
comparable to that of surgery.17 In patients with AVM
involving fingers (groups I and II), the complication rate
was especially high, and the possible cause is that the
above-mentioned characteristics were obvious in these pa-
tients. However, there was more therapeutic benefit in
finger AVMs, because lesions were smaller and thus the
required volume of ethanol was less than in AVMs involv-
ing both the palm and fingers.
Sofocleous et al10 reported favorable results with
NBCA embolization of AVMs in the hand and forearm.
Immediate technical success, which they defined as the
degree of devascularization greater than 75% of the AVM
on angiography, was obtained in 85%. Applying their defi-
nition of technical success, ours was 68% (21 of 31). How-
ever, 29% of their patients were lost to follow-up, while
only 3% of patients in our study were lost to follow-up.
There may be a debate over the types of embolic agents
used in the treatment of AVMs. In embolization with
NBCA, control of the level of occlusion is difficult; there-
fore, we may inevitably embolize the proximal feeding
artery or distal draining vein, resulting in inability to admin-
ister further treatment or venous hypertension. NBCA was
thought to be a permanent embolic agent; however, there
have been reports on the recanalization and neovascular
recruitment after complete occlusion with NBCA.2,18 Eth-
anol is known to induce protein denaturation of endothelial
cells with subsequent denudation of vessel wall and throm-
bus formation, resulting in complete obliteration and per-
manent damage to the AVM nidus.12,19,20 In terms of
these points, we prefer to use ethanol as the embolic agent
of choice for the treatment of AVMs.
Ethanol is known to cause pulmonary arterial hyperten-
sion and cardiopulmonary complications during treatment
of AVMs.21 According to the study, hemodynamic changes
can arise from single bolus injection rather than the total
amount of ethanol during a single session of treatment. No
greater than 0.14 mL/kg body weight of ethanol is safe for
single injection. Although we never exceeded that in our Series, we did pulmonary arterial monitoring with the
wan-Ganz catheter and arterial monitoring for safety in all
ur cases.
We used coils for the treatment of AVMs of the body
nd extremities with dilated draining vein, because coil
mbolization is useful in reducing the rate of arteriovenous
hunting, and, thus, the amount of ethanol, increasing the
ontact time of ethanol with the nidus of AVM, and sub-
equently increasing the therapeutic effect.8,12 In our se-
ies, there was 1 patient who had large draining veins and
ilated fistulae. This patient showed little response after
wo sessions of ethanol embolization. We used coil embo-
ization of the dilated draining vein, and the size and
ulsation of the AVMmass was dramatically decreased after
oil embolization. However, necrosis and delayed wound
ealing occurred, and coils were coming out of the wound.
oils were removed surgically and the wound healed. In
arrow spaces like the hand, packing of coils may result in
evelopment of pressure necrosis, as in our series, and,
hus, coil embolization should be reserved for patients with
severely dilated draining vein.
In 4 patients with a need for further treatment, cathe-
erization and puncture were impossible due to tortuosity
f feeding arteries and fine microfistulae. These can be an
bstacle to treatment of hand AVMs and less commonly
ncountered in other AVMs.
In AVMs involving fingers (groups I and II), there was
relatively high rate of complications in comparison with
VM without finger involvement. AVM involving both
nger and palm (group II), which involves wider extent,
howed a lower rate of therapeutic benefit than the two
ther groups.
The limitations of this study included its retrospective
ature and the small sample size of each group, which
recludes the ability to detect differences in clinical out-
ome between the groups.
In conclusion, hand AVM is one of the most challeng-
ng diseases because the complication rate is relatively high
ith acceptable treatment response. In our series, there was
trend toward a higher complication rate in the treatment
f AVMs involving fingers and a lower rate of therapeutic
enefit in AVMs involving both the finger and the palm. In
rder to reduce the complication rate and to increase the
herapeutic effect, it is important to identify feeding vessels
nd nidus with thorough angiography and to decide on the
roper strategy with regard to the access route and the
mount and infusion rate of ethanol.
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